Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Armstrong, DPM, MD, PhD
USC Keck School of Medicine - Salsa
Principal Investigator - Robert Galiano, MD
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Center for Clinical Research
San Francisco, California, United States
- Gateway Clinical Trials Llc
O'Fallon, Illinois, United States
- Lower Extremity Institute of Research and Therapy
Youngstown, Ohio, United States
- Martinsville Research Institute
Martinsville, Virginia, United States
- Foot and Ankle Associates of Southwest Va
Salem, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 2019
- Primary completion
- 14 Sept 2021
- Completion
- 1 Oct 2021
- Last update posted
- 28 Jan 2022
- Registered enrollment
- 100
- Registry id
- NCT04040426
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.